We by Thursday. NOV2020
DNA Microarray Lab Results
1 Which genes were expressed in lung cancer cells? How are you sure of this?
2. Which gene(s) were not expressed in the lung cancer cells? How are you sure of this?
3 Were there any genets) that were expressed in Both cell types
4 were any genes hat were not expressed in the two
2
Answers
Answer:
Home
NTRK Fusion+ Cancer
ROS1 Fusion+ Cancer
Precision Medicine in Rare Cancer
Fusion Detection
For patients with solid tumours,
Let testing be your guide
Every cancer is unique. Let’s treat it that way
Targeted therapies are being studied to advance treatment options for patients with actionable biomarkers – patients with gene fusions need high quality molecular testing to realise these opportunities.1,2
To help patients with NTRK or ROS1 fusion+ cancer, we must first identify them. #PutCancerToTheTest
NTRK fusion positive genes are emerging as actionable biomarkers and oncogenic drivers across a wide range of tumour types.1–6 NTRK fusion+ cancer currently has no known defining clinical or pathological features.1–3
Only high quality molecular testing such as next-generation sequencing (NGS) can confirm